| Number | | | Description | | |
| 3.1 | | | Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 29, 2022). | | |
| 3.2 | | | Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 29, 2022). | | |
| 10.1 | | | GE HealthCare Founders Restricted Stock Unit Grant Agreement (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed with the SEC on February 3, 2023). | | |
| 10.2 | | | GE HealthCare Founders Stock Option Grant Agreement (incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K filed with the SEC on February 3, 2023). | | |
| 10.3 | | | GE HealthCare Restricted Stock Unit Grant Agreement (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed with the SEC on March 3, 2023). | | |
| 10.4 | | | GE HealthCare Stock Option Grant Agreement (incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K filed with the SEC on March 3, 2023). | | |
| 10.5 | | | GE HealthCare Performance Stock Unit Grant Agreement (incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed with the SEC on March 3, 2023). | | |
| 10.6 | | | Global Addendum (incorporated by reference to Exhibit 10.3 to the Registrant's Current Report on Form 8-K filed with the SEC on February 3, 2023). | | |
| 10.7 | | | One GE HealthCare Annual Bonus Plan (incorporated by reference to Exhibit 10.4 to the Registrant's Current Report on Form 8-K filed with the SEC on February 3, 2023). | | |
| 10.8 | | | GE HealthCare US Severance and Change in Control Plan for CEO and Leadership Team (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed with the SEC on March 24, 2023). | | |
| 10.9 | | | GE HealthCare Non-Employee Director Compensation and Benefits Plan. | | |
| 10.10 | | | GE HealthCare Director Restricted Stock Unit Grant Agreement. | | |
| 10.11 | | | GE HealthCare Director Deferred Stock Unit Grant Agreement. | | |
| 10.12 | | | Offer Letter with Helmut Zodl, dated November 25, 2020. | | |
| 10.13 | | | Offer Letter with Frank R. Jimenez, dated February 4, 2022. | | |
| 10.14 | | | Offer Letter with Betty D. Larson, dated January 21, 2022. † | | |
| 10.15 | | | Employment Contract with Jan Makela, dated February 24, 2023. | | |
| 31.1 | | | Certification of the Registrant's Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2022. | | |
| 31.2 | | | Certification of the Registrant's Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | |
| 32.1 | | | Certifications of the Registrant's Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | |
| 101 | | | The following materials from GE HealthCare Technologies Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in inline XBRL (eXtensible Business Reporting Language); (i) Condensed Consolidated and Combined Statements of Income for the three months ended March 31, 2023 and 2022; (ii) Condensed Consolidated and Combined Statements of Comprehensive Income for the three months ended March 31, 2023 and 2022; (iii) Condensed Consolidated and Combined Statements of Financial Position at March 31, 2023 and December 31, 2022; (iv) Condensed Consolidated and Combined Statements of Changes in Equity at March 31, 2023 and December 31, 2022; (v) Condensed Consolidated and Combined Statements of Cash Flows for three months ended March 31, 2023 and 2022; and (vi) Notes to the Condensed Consolidated and Combined Financial Statements. | | |
| 104 | | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | | |
| † | | | Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) and Item 601(b)(10)(iv) of Regulation S-K, as applicable. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request. | | |
filings.tools